Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2025 · research · Research Grant
Clinical Development of the PET Tracer Candidate MODAG-009 for quantitative Detection of Alpha-synuclein Pathology in Parkinson’s Disease
Armin Giese · Modag Gmbh
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
CT600 as a Neuroprotective Peptide Therapeutic for Parkinson’s Disease
John Kent Werner · Cogentis Therapeutix, Inc.
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
SUPPLEMENT: A Novel Immunotherapy for the Treatment of Parkinson’s Disease
Manuel Blanc · Lys Therapeutics
2025 · research · Research Grant
A Meta-Analysis of Single Nucleus Allele Specific Expression to Investigate Parkinson's Disease
Sean Simmons · Broad Institute
2025 · research · Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program
Predicting Freezing of Gait in Parkinson’s Disease: An Objective Quantitative Exploration Combining Patient Perception with Multi-Dimensional Digital Gait Analysis & Multi-Domain Cognitive Testing
Mark Gudesblatt · New York University
2025 · research · Research Grant
Powered Clothing and Wearable Robotics for Improved Gait, Balance and Reduced Freezing in Everyday Life
Kathryn Zealand · Skip Innovations
2025 · research · Research Grant
Alpha-synuclein PET Imaging in Patients
Stephen Gomperts · Massachusetts General Hospital
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Investigating the Mechanisms of Alpha-synuclein-induced Anxiety in a Novel Preclinical Model of Parkinson’s Disease
Christopher Bishop · Binghamton University
2025 · research · Spring 2025 RFA: Molecular MRI Biomarker Program
Rapid and Quantitative Multi-metabolite Imaging in Parkinson’s Disease using AI Boosted Chemical Exchange Saturation Transfer Magnetic Resonance Fingerprinting (CEST MRF)
Or Perlman · Tel Aviv University
2025 · research · Research Grant
The BioFINDER Studies: Identifying Disease Stages and Effects of Co-morbidities in Neuronal Synuclein Disease
Oskar Hansson · Lund University
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
Lead Optimization of a B1-selective AMPK-activator for Treatment of PD
Tereza Moore · Evvia Therapeutics
2025 · research · Research Grant
Investigating Aggregate-specific Alpha-synuclein Antibodies and Proximity Ligation Assay as Quantitative Biomarkers in Parkinson’s Disease
Nanna Møller Jensen · Aarhus University
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Matthew S. Goldberg · University of Alabama at Birmingham
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Evaluating Modifiable Risk Factors for Parkinson’s Disease in the Global Burden of Disease Study
Michael Brauer · University of Washington
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Identifying Biochemical, Histological and Molecular Signatures of Constipation Associated with Parkinson’s Disease
Inga Peter · Icahn School of Medicine at Mount Sinai
2025 · research · Research Grant
Scamps: Endosomal Membrane Proteins that Control Alpha-synuclein Traffic
Randy Schekman · Aligning Science Across Parkinson's
2025 · research · iPSC Phenotyping Environmental Exposure Program
Assessing How Triplication of the Alpha-synuclein Gene Affects Electrophysiological and Mitochondrial Phenotypes in Neurons, Astrocytes and Microglia
Lezanne Ooi · University of Wollongong
2025 · research · Research Grant
Construction of a Living Library of Digital Technologies for Use in Research and Care of Parkinson’s Disease.
Anat Mirelman · Aviv University
2025 · research · Research Grant
SUPPLEMENT: Cytokine Production by Adaptive Immune Cells from Patients with Parkinson’s Disease: Response to Diverse Biological Stimuli
Etty (Tika) N. Benveniste · University of Alabama at Birmingham
2025 · research · T2T Validation - Endolysosomal Targets
Exploring TMEM175 as a Key Target in the Pathogenesis of Parkinson's Disease
Ziv Gan-Or · McGill University
2025 · research · Research Grant
Applying the Neuronal Alpha-synuclein Disease Integrated Staging System in Multiple System Atrophy
Wassilios Meissner · Centre Hospitalier Universitaire de Bordeaux
2025 · research · Research Grant
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD.
Prabesh Kanel · University of Michigan
2025 · research · Research Grant
Standardization and Validation of Neuromelanin-Sensitive MRI Biomarkers for Disease Progression in Parkinson’s Disease Using PPMI Data
Roger Gunn · Xing Imaging – A Xing Imaging Company
2025 · research · Research Grant
Analysis of 18F-DPA714 Dynamic Data with Arterial Sampling Obtained at UAB
Roger Gunn · Xing Imaging – A Xing Imaging Company
2025 · research · Research Grant
Evaluation of Novel PET Probes for Alpha-synuclein Imaging
Vikram Khurana · Harvard University
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD- Biology
Investigating the Interplay Between Mitochondrial DNA-containing VDIMs (vesicles derived from inner mitochondrial membrane) and LRRK2-dependent Lysosomal Defects in Parkinson’s Disease
Maria Rosa Puertollano Moro · National Heart, Lung And Blood Institute; National Institutes Of Health
2025 · research · Accelerating Biological Understanding and Therapeutic Translation for PD- Biology
Role of TFEB Pathway Activators and ISR Inhibitors on Alpha-synuclein Associated Impaired Mitophagy in the a Pre-clinical Model Brain
Ian G. Ganley · University of Dundee
2025 · research · Research Grant
From Omics to Action: A Multimodal Pipeline for Druggable Target Discovery and Real-world Validation in PD
Xianjun Dong · Yale University
2025 · research · Summer 2021 RFP: Expanding Biological Understanding of PD
SUPPLEMENT: Urinary Biomarkers of Retromer Dysfunction in Parkinson’s Disease
Sabrina Simoes · Columbia University, Taub Institute
2025 · research · MRI Biomarkers Program
Validate Diffusion MRI Biomarkers of Early PD: A Multi-cohort Study of Free-water and CDM Measure
Duygu Tosun-Turgut · University of California, San Francisco
2025 · research · Research Grant
Planning for a LRRK2 Platform Trial
Andrew Siderowf · University of Pennsylvania
2025 · research · Research Grant
(SUPPLEMENT) Enhancing Brain Clearance Mechanisms to Limit Parkinson Disease Progression
Jason A. Howitt · Swinburne University of Technology
2025 · research · Accelerating Biological Understanding and Therapeutic Translation For Parkinson’s Disease- Biology
(SUPPLEMENT) Validation of LRRK2 Modifiers as Potential PD Therapeutic Targets
Jean-Marc Taymans · Umr-s1172, Jean-pierre Aubert Research Center (inserm - Lille University - Lille University Hospital
2025 · research · T2T Validation - NOD2
Inflammatory and Regulatory Functions of NOD2 in the Setting of Parkinson’s Disease
Justine T. Tigno-Aranjuez · The University Of Central Florida Board Of Trustees
2025 · research · Parkinson’s Disease Therapeutics Pipeline Program
PINK1 Activators for Treating Parkinson's Disease
Kumar Suresh · Progenra Inc.
2025 · research · Neuronal Synuclein Disease Endotypes 2024
Developing a Method to Exclude Individuals with Insignificant Alpha-synuclein Aggregates from Trials of Therapies that Target Alpha-synuclein
Paul Christopher Donaghy · Newcastle University
2025 · research · Research Grant
Clinical Evaluation of 18F-FD4 as a Potential Alpha-synuclein PET Imaging Biomarker
Roger Gunn · Xing Imaging – A Xing Imaging Company
2025 · research · Research Grant
A Comparative Performance Study between High and Standard Resolution Positron Emission Tomography Camera using [18F]AV-133 in Prodromal Parkinson’s Disease [Dual PET AV133 in Prodromal PD]
Neha Prakash · Institute For Neurodegenerative Disorders And Xingimaging, Llc
2025 · research · MJFF Funded Study
Harmonization of LRRK2 Parkinson’s Disease Cohorts
Ruth Schneider · University of Rochester
2025 · research · Summer 2025 RFP: Accelerating Biological Understanding and Translational Approaches for PD Program - Biomarkers
EV-PREDICT: Identifying Early Biomarkers for Parkinson’s Disease in Blood-derived Neuronal Vesicles
Inge Mertens · Flemish Institute for Technological Research